The cooperation between Meili Technology and Shenzhen University of Technology this time is not focused on delivering a single device, but exploring long-term cooperation models. As a practitioner of independent innovation in domestic nanopore products, Meili Technology has always adhered to the principle of“ Technological breakthroughs+scenario implementation; As the core, we are committed to opening up the core technical parameters of instruments, developing customized functions, and supporting the development of customized sequencing/detection methods; At the same time, it provides opportunities for scientific research project cooperation to assist universities in transforming sequencing data into scientific research achievements such as papers and patents, accelerating the process of industry university research integration.
As a high-tech company relying on the fourth generation (nanopore) gene sequencing technology, Meili Technology develops commercial single-molecule sequencing instruments and supporting reagents with ultra long read length, no amplification, fast, accurate, and low cost. By integrating the entire product cycle of sample preparation, database construction, sequencing, bioinformatics analysis, and report generation, Meili Technology will continuously lower the threshold for product use, promote the popularization of precision medicine, and safeguard the health of patients.